Elsevier

Life Sciences

Volume 26, Issue 16, 21 April 1980, Pages 1293-1302
Life Sciences

Properties of 3H-cimetidine binding in rat brain membrane fractions

https://doi.org/10.1016/0024-3205(80)90088-0Get rights and content

Abstract

In an attempt to characterize the brain histamine H2 receptor, experiments were undertaken to study the binding properties of (N-methyl-3H) -cimetidine, an H2 receptor antagonist, in rat brain membranes. Using a centrifugation assay, 3H-cimetidine binding having a Kd of 0.40μM and a Bmax of 3.9 pmoles/mg protein was detected. Of fourteen anions and cations tested, one, Cu++, dramatically increased specific 3H-cimetidine binding, the increase being due mainly to a change in Bmax. Studies of substrate specificity for 3H-cimetidine binding revealed that Cu++, while not significantly affecting the potency of H2 receptor agonists and antagonists, dramatically decreases the potency of H1 receptor substances on the 3H-cimetidine binding site. In addition, both the relative and absolute potencies of various H2 receptor agonistsv and antagonists in displacing the ligand in the presence of Cu++ parallels their potencies in biological systems. These findings suggest that, under these conditions, 3H-cimetidine may be labelling a biologically relevant H2 binding site in brain and that Cu++ may regulate the substrate specificity for this site. The brain regional distribution and kinetic analysis of the binding suggest that it is not localized solely to the synaptic receptor for histamine, but may also be associated with histamine receptors at other neuronal, glial or vascular sites.

References (20)

  • J.C. Schwartz

    Life Sciences

    (1979)
  • P.D. Kanof et al.

    Arch. Biochem. Biophys.

    (1977)
  • W.P. Burkard

    Europ. J. Pharmacol.

    (1978)
  • O.H. Lowry et al.

    J. Biol. Chem.

    (1951)
  • D.L. Gruol et al.

    Brain Res.

    (1979)
  • S.J. Enna et al.

    Brain Res.

    (1975)
  • D.C. U'Prichard et al.

    Brain Res.

    (1977)
  • J.C. Schwartz

    Ann. Rev. Pharmacol. Toxicol.

    (1977)
  • P.D. Kanof et al.

    J. Pharmacol. Exptl. Therap.

    (1979)
  • V.T. Tran et al.
There are more references available in the full text version of this article.

Cited by (0)

View full text